Question 1

What is the analyst consensus rating for MREO?

Accepted Answer

The analyst consensus rating for MREO is "Buy" based on 4 analyst recommendations.

Question 2

What is the average price target for MREO?

Accepted Answer

The average 12-month price target for MREO is $1.50, representing an upside of 260.8% from the current price of $0.42.

Question 3

What do analyst ratings mean?

Accepted Answer

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

Question 4

What is a price target?

Accepted Answer

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

Date	Analyst	Firm	Action	Rating	Price Target
Jan 16, 2026	Julian Harrison	BTIG	Reiterates	Strong Buy	$1.00 → $1.00 +0.00 (0.0%)
Jan 13, 2026	Gil Blum	Needham	Maintains	Strong Buy	$5.00 → $3.00 -2.00 (-40.0%)
Dec 30, 2025	Maury Raycroft	Jefferies	Downgrades	Hold	$7.00 → $0.50 -6.50 (-92.9%)
Dec 29, 2025	Cory Jubinville	LifeSci Capital	Downgrades	Hold	-
Dec 29, 2025	Julian Harrison	BTIG	Maintains	Strong Buy	$6.00 → $1.00 -5.00 (-83.3%)
Dec 22, 2025	Gil Blum	Needham	Reiterates	Strong Buy	$5.00 → $5.00 +0.00 (0.0%)
Dec 18, 2025	Julian Harrison	BTIG	Reiterates	Strong Buy	$6.00 → $6.00 +0.00 (0.0%)

Mereo BioPharma Group (MREO) Stock Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Average Price Target

Latest MREO Analyst Ratings & Recommendations